Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2014 | The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cells | Lin Y.-H.; Chen B.Y.-H.; Lai W.-T.; Wu S.-F.; JIH-HWA GUH ; ANN-LII CHENG ; LIH-CHING HSU | Naunyn-Schmiedeberg's Archives of Pharmacology | 34 | 32 | |
2021 | ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240 | Vogel, Arndt; Merle, Philippe; Verslype, Chris; Finn, Richard S; Zhu, Andrew X; ANN-LII CHENG ; Chan, Stephen Lam; Yau, Thomas; Ryoo, Baek-Yeol; Knox, Jennifer; Daniele, Bruno; Qin, Shukui; Wei, Ziwen; Miteva, Yanna; Malhotra, Usha; Siegel, Abby B; Kudo, Masatoshi | Therapeutic advances in medical oncology | 7 | 6 | |
2023 | Albumin-Bilirubin Grade Analyses of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 Study | Kudo, Masatoshi; Finn, Richard S; ANN-LII CHENG ; Zhu, Andrew X; Ducreux, Michel; Galle, Peter R; Sakamoto, Naoya; Kato, Naoya; Nakano, Michitaka; Jia, Jing; Vogel, Arndt | Liver cancer | 2 | | |
1987 | Allogeneic bone marrow transplantation in the treatment of leukemia--a preliminary report | YAO-CHANG CHEN ; Wang C.H.; Lin D.T.; Lui P.T.; ANN-LII CHENG ; Liu T.W.; WOEI TSAY ; HWEI-FANG TIEN ; Liu M.C.; Chuu W.M. | Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association | 0 | 0 | |
1994 | An alternative method to overcome central venous portable external infusion pump blockage in patients receiving weekly 24-hour high-dose fluorouracil and leucovorin [2] | KUN-HUEI YEH ; ANN-LII CHENG | Journal of Clinical Oncology | 18 | 16 | |
1997 | Angioimmunoblastic lymphadenopathy with dysproteinemia - lack of a prognostic value of clear cell morphology | Ch’ang H.-J.; Su I.J.; Chen C.L.; Zmija I.P.; YAO-CHANG CHEN ; Wang C.H.; ANN-LII CHENG | Oncology (Switzerland) | 7 | 7 | |
2021 | Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients | I-CHUN CHEN ; Hu, Fu-Chang; CHING-HUNG LIN ; Huang, Shu-Min; DWANG-YING CHANG ; ANN-LII CHENG ; YEN-SHEN LU | Breast (Edinburgh, Scotland) | 2 | 2 | |
2011 | Antiangiogenic strategies for the treatment of hepatocellular carcinoma | CHIUN HSU ; Ying-Chun Shen ; ANN-LII CHENG | Targeted Therapies for Hepatocellular Carcinoma | 0 | 0 | |
2021 | APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy | Lau G.; Yu M.-L.; Wong G.; Thompson A.; Ghazinian H.; Hou J.-L.; Piratvisuth T.; Jia J.-D.; Mizokami M.; Cheng G.; Chen G.-F.; Liu Z.-W.; Baatarkhuu O.; ANN-LII CHENG ; Ng W.L.; Lau P.; Mok T.; Chang J.-M.; Hamid S.; Dokmeci A.K.; Gani R.A.; Payawal D.A.; Chow P.; Park J.-W.; Strasser S.I.; Mohamed R.; Win K.M.; Tawesak T.; Sarin S.K.; Omata M. | Hepatology International | 52 | 41 | |
2018 | The APPLE association president's message | ANN-LII CHENG | Liver Cancer | 0 | 0 | |
2018 | The APPLE Association President's Message | ANN-LII CHENG | Liver Cancer | 0 | 0 | |
2019 | The APPLE association president's message | ANN-LII CHENG | Liver Cancer | 0 | 0 | |
2018 | The APPLE Association President's Message | ANN-LII CHENG | Liver Cancer | 0 | 0 | |
2019 | The APPLE Association President's Message | ANN-LII CHENG | Liver Cancer | 0 | 0 | |
2017 | The APPLE Association President's Message | ANN-LII CHENG | Liver Cancer | 0 | 0 | |
2019 | The APPLE association president's message | ANN-LII CHENG | Liver Cancer | 0 | 0 | |
2009 | Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - Analysis of 2010 Taiwanese patients | CHIEN-HUNG CHEN ; Hu F.-C.; GUAN-TARN HUANG ; PO-HUANG LEE ; Tsang Y.-M.; ANN-LII CHENG ; DING-SHINN CHEN ; Wang J.-D.; JIN-CHUAN SHEU | European Journal of Cancer | 68 | 64 | |
2007 | Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial | CHIA-CHI LIN ; CHIUN HSU ; CHIH-HUNG HSU ; Hsu W.-L.; ANN-LII CHENG ; CHIH-HSIN YANG | Investigational New Drugs | 104 | 103 | |
2011 | Asian consensus workshop report: Expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia | Han K.-H.; Kudo M.; Ye S.-L.; Choi J.Y.; Poon R.T.-P.; Seong J.; Park J.-W.; Ichida T.; Chung J.W.; Chow P.; ANN-LII CHENG | Oncology | 98 | 98 | |
2010 | Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma | Omata M.; Lesmana L.A.; Tateishi R.; PEI-JER CHEN ; Lin S.-M.; Yoshida H.; Kudo M.; Lee J.M.; Choi B.I.; Poon R.T.P.; Shiina S.; ANN-LII CHENG ; Jia J.-D.; Obi S.; Han K.H.; Jafri W.; Chow P.; Lim S.G.; Chawla Y.K.; Budihusodo U.; Gani R.A.; Lesmana C.R.; Putranto T.A.; Liaw Y.F.; Sarin S.K. | Hepatology International | 881 | 860 | |